No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19

BACKGROUND: Some studies have shown that hydroxychloroquine (HCQ) is an effective drug in reducing the in vitro replication of SARS-CoV-2. However, the in vivo effect of HCQ still unclear. OBJECTIVES: This study aims to evaluate viral load clearance in patients with COVID-19 who underwent HCQ treatm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Braz J Microbiol
Hlavní autoři: Faíco-Filho, Klinger Soares, Conte, Danielle Dias, de Souza Luna, Luciano Kleber, Carvalho, Joseane Mayara Almeida, Perosa, Ana Helena Sitta, Bellei, Nancy
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2020
Témata:
Clinical Microbiology - Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592126/
https://ncbi.nlm.nih.gov/pubmed/33111169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s42770-020-00395-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky